Evaluation of Potentially Inappropriate Medications (PIMs) in Outpatient Geriatric Patients at RSKO Jakarta
Main Article Content
Abstract
Introduction: The global incidence of Potentially Inappropriate Medication Use (PIM) in elderly patients ranges from 6% to 41%. Research indicates that some medications are not recommended for elderly patients due to their side effects outweighing clinical benefits. The American Geriatrics Society developed the Beers Criteria as guidelines in clinical practice and research to identify PIM and guide medication management in elderly patients. This study aims to assess the prevalence of inappropriate medication prescriptions in elderly outpatients at RSKO Jakarta using the Beers Criteria. Additionally, the study analyzes the relationship between polypharmacy and comorbidities with PIM occurrence.
Methods: The sample consists of elderly patients from general and internal medicine clinics at RSKO Jakarta from January to August 2023. This non-experimental study employs a descriptive approach, collecting retrospective data from 110 prescriptions. The data is analyzed univariately and bivariately using the chi-square test to determine the relationships between polypharmacy, comorbidities, and the occurrence of PIM.
Results: The study found that 53.64% of prescriptions for elderly patients at RSKO Jakarta were identified as PIMs, with 11.54% categorized under "avoid" and 88.46% under "use with caution." The most commonly prescribed PIMs were glimepiride (16.25%), gabapentin (15%), and omeprazole (13.75%). The findings indicate a significant relationship between polypharmacy (p=0.000) and comorbidities (p=0.000) with PIM occurrence.
Conclusion: These results highlight the need for further evaluation of medication prescribing patterns for elderly patients at RSKO Jakarta. The significant association between polypharmacy and comorbidities with PIM occurrence underscores the importance of careful medication management in this population, using guidelines such as the Beers Criteria to minimize the risks of inappropriate medication use.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Halvorsen K, Kucukcelik S, Garcia B, Svendsen K. Assessing Potentially Inappropriate Medications in Nursing Home Residents by NORGEP-NH Criteria. Pharmacy. 2019;7(1):26.
II. Wulansari A, Wiedyaningsih C, Probosuseno P. Potentially Inappropriate Medication (PIM) pada Pasien Geriatri Rawat Inap di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Maj Farm. 2023;19(1):91.
III. Rahmawati R, Harianti Putri Y, Handayani D, Pertiwi R, Putri Nurlita S, Kamilla Putri D, et al. Potensi Penggunaan Obat Tidak Tepat Pada Pasien Rawat Jalan Geriatri Berdasarkan Kriteria Beers 2019 Potentially Inappropriate Medication in Geriatric Outpatients Based on Beers Criteria 2019. Jurna AKFARINDO. 2022;7(2):60–5.
IV. Alhawassi TM, Krass I, Bajorek B, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079–86.
V. By the 2019 American Geriatrics Society Beers Criteria®. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Am Geriatr Soc. 2019.
VI. Khairunnisa, Ananda MR. Penggunaan Obat Pada Pasien Geriatri Di Instalasi Rawat Jalan Rumah Sakit Universitas Sumatera Utara. Maj Farm dan Farmakol [Internet]. 2023;1(6):6–10. Available from: http://journal.unhas.ac.id/index.php/mff
VII. Mahendra E, Tosepu R, Asriati. HUBUNGAN KOMORBID DENGAN KEPARAHAN COVID-19 DI RUMAH SAKIT DARURAT COVID-19 WISMA ATLET KEMAYORAN JAKARTA PUSAT TAHUN 2022 1 Prodi Kesehatan Masyarakat, Pasca Sarjana Universitas Halu Oleo, Kendari, Indonesia 2 Fakultas Kesehatan Masyarakat, U. Ilm Olahraga. 2022;289–300.
VIII. Wulandari N, Andrajati R, Supardi S. Faktor Risiko Umur Lansia terhadap Kejadian Reaksi Obat yang Tidak Dikehendaki pada Pasien Hipertensi, Diabetes, Dislipidemia di Tiga Puskesmas di Kota Depok. J Kefarmasian Indones. 2016;6(1):60–7.
IX. Qato DM, Wilder J, Schumm LP, Gillet VS, Alexander GC. Changes in Prescription and Over the Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473‐82. 2017;176(12):139–48.
X. Goel V, Rosella LC, Fu L, Alberga A. The Relationship Between Life Satisfaction and Healthcare Utilization: A Longitudinal Study. Am J Prev Med [Internet]. 2018;55(2):142–50. Available from: http://dx.doi.org/10.1016/j.amepre.2018.04.004
XI. Boult C, Boult L, Murphy C, Ebbitt B, Luptak M, Kane RL. A Controlled Trial of Outpatient Geriatric Evaluation and Management. J Am Geriatr Soc. 1994;42(5):465–70.
XII. Curioni C, Silva AC, Damião J, Castro A, Huang M, Barroso T, et al. The Cost-Effectiveness of Homecare Services for Adults and Older Adults: A Systematic Review. Int J Environ Res Public Health. 2023;20(4).
XIII. Rumi A, Faisal M, Syarifuddin N, Purwanti R, Natasya P, Serli S. Gambaran penggunaan obat pada pasien geriatri di Puskesmas Dolo Kabupaten Sigi. J Keperawatan Komunitas. 2023;12(1):1–11.
XIV. Okuyama T. Gender differences in pharmacokinetics and pharmacodynamics. Drug Metab Dispos. 2016;44(11):1636–52.
XV. Wahyuni KSPD, Widyaningrum EA, Sari EA, Noerhalizah D. Hubungan Jumlah Peresepan Obat Terhadap Potentially Inappropriate Medications Berdasarkan Beers Criteria 2023 Pasien Diabetes Mellitus. Indones J Pharm Educ. 2023;3(2):195–202.
XVI. AMANDA MP, HUMAEDI S, SANTOSO MB. Penyalahgunaan Narkoba Di Kalangan Remaja (Adolescent Substance Abuse). Pros Penelit dan Pengabdi Kpd Masy. 2017;4(2):339–45.
XVII. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. 2023;Volume 71(7).
XVIII. An A, Hadits DAN. Konsep Sistem Pencernaan pada Manusia berdasarkan Al-quran dan Hadits. J Penelitian, Pendidik dan Pengajaran JPPP. 2022;3(3):244–51.
XIX. Misrina T, Intannia D, Lingga HN, Rahmatullah SW. Potentially Inappropriate Medications (PIMs) dan Potentially Prescribing Omissions (PPOs) pada Pasien Geriatri Rawat Inap. J Pharmascience. 2023;10(2):296.
XX. Kumala MT, Suharti T, Prameswari S. Gambaran Penggunaan Obat pada Pasien Geriatri di Puskesmas Dolo Kabupaten Sigi. J Keperawatan Komunitas. 2023;12(1):1–11.
XXI. Hamidah KF, Rahmadi M, Meutia F, Kriswidyatomo P, Rahman FS, Izzah Z, et al. Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia. Pharm Pract (Granada). 2022;20(4):1–11.
XXII. Davidson J. Glimepiride: A Review of Its Use in the Management of Type 2 Diabetes Mellitus. Drugs Aging. 2021;38(12):947–56.
XXIII. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):668–72.
XXIV. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American college of physicians. Ann Intern Med. 2018;168(8):569–76.
XXV. Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4(6):640–50.
XXVI. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Vol. 117, American Journal of Gastroenterology. 2022. 27–56 p.
XXVII. Kanno T, Moayyedi P. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem. Curr Gastroenterol Rep. 2019;21(12).
XXVIII. Kurin M, Fass R. Management of Gastroesophageal Reflux Disease in the Elderly Patient. Drugs and Aging [Internet]. 2019;36(12):1073–81. Available from: https://doi.org/10.1007/s40266-019-00708-2
XXIX. Gomm W, Von Holt K, Thomé F, Broich K, Maier W, Fink A, et al. Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol. 2016;73(4):410–6.
XXX. Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab. 2015;19(6):744–52.
XXXI. Rapid T, Service R, Cadth W. Review of the Clinical Effectiveness and Safety – An Update: Glyburide, Gliclazide or Glimepiride for Elderly Patients with Type 2 Diabetes: A Review of the Clinical Effectiveness and Safety – An Update. 201